Immuron Ltd Files October 2024 Report on Form 6-K
Ticker: IMRN · Form: 6-K · Filed: Oct 15, 2024 · CIK: 1660046
| Field | Detail |
|---|---|
| Company | Immuron LTD (IMRN) |
| Form Type | 6-K |
| Filed Date | Oct 15, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, regulatory-update
Related Tickers: IMRN
TL;DR
IMRN filed a 6-K for Oct 2024, just an update filing.
AI Summary
Immuron Limited filed a Form 6-K on October 15, 2024, reporting its activities for the month of October 2024. The filing indicates that the company is a foreign private issuer and is furnishing information to the SEC under Rule 13a-16 or 15d-16. The report includes one published announcement.
Why It Matters
This filing provides an update on Immuron Limited's regulatory disclosures, which is important for investors tracking the company's compliance and ongoing reporting obligations.
Risk Assessment
Risk Level: low — This filing is a routine report of foreign private issuer activities and does not contain significant new financial or operational information that would inherently increase risk.
Key Players & Entities
- Immuron Limited (company) — Registrant
- October 2024 (date) — Reporting period
- United States Securities and Exchange Commission (company) — Regulatory body
- Rule 13a-16 (legal_document) — Reporting rule
- Rule 15d-16 (legal_document) — Reporting rule
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose is to report information that Immuron Limited has made or is required to make public in Australia, or has distributed or made available to its security holders, for the month of October 2024.
Is Immuron Limited filing an annual report on Form 20-F or 40-F?
Yes, Immuron Limited indicates it files annual reports under cover of Form 20-F.
Is Immuron Limited furnishing information under Rule 12g3-2(b)?
No, Immuron Limited has marked 'No' for furnishing information under Rule 12g3-2(b).
What is the principal executive office address for Immuron Limited?
The principal executive office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
What is the SIC code for Immuron Limited?
The Standard Industrial Classification (SIC) code for Immuron Limited is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 312 words · 1 min read · ~1 pages · Grade level 18.6 · Accepted 2024-10-15 08:00:07
Filing Documents
- ea0217598-6k_immuron.htm (6-K) — 13KB
- ea021759801ex99-1_immuron.htm (EX-99.1) — 13KB
- ex99-1_001.jpg (GRAPHIC) — 5KB
- ex99-1_002.jpg (GRAPHIC) — 16KB
- ex99-1_003.jpg (GRAPHIC) — 7KB
- ex99-1_004.jpg (GRAPHIC) — 3KB
- 0001213900-24-087487.txt ( ) — 70KB
From the Filing
OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of October 2024 Commission File Number: 001-38104 IMMURON LIMITED (Name of Registrant) Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes No If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- IMMURON LIMITED EXPLANATORY NOTE Immuron Limited (the “Company”) published one announcement (the “Public Notices”) to the Australian Securities Exchange on October 15, 2024 titled: - “Immuron Travelan continued strong sales growth” A copy of the Public Notice is attached as an exhibit to this report on Form 6-K. This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. 1 EXHIBITS Exhibit Number Description 99.1 Immuron Travelan continued strong sales growth 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IMMURON LIMITED Date: October 15, 2024 By: /s/ Phillip Hains Phillip Hains Company Secretary 3